VALUE OF THE DETECTION OF NEUROENDOCRINE DIFFERENTIATION IN PROSTATE CANCER

VALUE OF THE DETECTION OF NEUROENDOCRINE DIFFERENTIATION IN PROSTATE CANCER

Show other versions (1)

Background. Many investigators point out the importance of detecting the neuroendocrine differentiation of prostate adenocarcinoma (PA) and consider its relationship to the clinical picture of the disease and total Gleason scores (Gleason index).Objective: to study relations between the presence of...

Full description

Bibliographic Details
Main Authors:	M. V. Kovylina, E. A. Prilepskaya, I. P. Sergeiko, T. N. Moiseenko, K. B. Kolantarev, A. V. Govorov, D. Yu. Pushkar
Format:	Article
Language:	Russian
Published:	ABV-press 2014-07-01
Series:	Onkourologiâ
Subjects:	prostate cancer radical prostatectomy neuroendocrine differentiation immunohistochemical studies gleason index chromogranin a synaptophysin
Online Access:	https://oncourology.abvpress.ru/oncur/article/view/142

Similar Items

VALUE OF THE DETECTION OF NEUROENDOCRINE DIFFERENTIATION IN PROSTATE CANCER
by: M. V. Kovylina, et al.
Published: (2014-07-01)

Focal Neuroendocrine Differentiation of Conventional Prostate Adenocarcinoma as a Prognostic Factor after Radical Prostatectomy: A Systematic Review and Meta-Analysis
by: Mehdi Kardoust Parizi, et al.
Published: (2019-03-01)

Primary neuroendocrine carcinoma of the breast
by: Akhtar Kafil, et al.
Published: (2009-01-01)

Immunohistochemical investigation of neuroendocrine component in prostate adenocarcinoma
by: Prokopyk O. V., et al.
Published: (2010-01-01)

PROGNOSTIC VALUE OF THE IMMUNOHISTOCHEMICAL MARKERS KI-67 AND P53 AFTER RADICAL PROSTATECTOMY
by: M. V. Kovylina, et al.
Published: (2014-07-01)

PROGNOSTIC VALUE OF THE IMMUNOHISTOCHEMICAL MARKERS KI-67 AND P53 AFTER RADICAL PROSTATECTOMY
by: M. V. Kovylina, et al.
Published: (2014-07-01)

Neuroendocrine Carcinoma of the Stomach-A Case Report
by: Poorana Priya P., et al.
Published: (2014-02-01)

Prostate cancer and neuroendocrine differentiation: More neuronal, less endocrine?
by: Alexandru Dan eGrigore, et al.
Published: (2015-03-01)

CHROMOGRANIN-A IN THE DIAGNOSIS OF PROSTATE CANCER
by: A. V. Sivkov, et al.
Published: (2015-04-01)

The Prognostic Significance of Neuroendocrine Differentiation in Colorectal Carcinomas: Our Experience
by: Pooja Kundapur Suresh, et al.
Published: (2015-12-01)

Significance of chromogranin A and synaptophysin in pancreatic neuroendocrine tumors
by: Tatsuo Tomita
Published: (2020-02-01)

Correlation between Gleason Scores of Prostatic Biopsies and Radical Prostatectomy Specimens
by: Panitta Sitthinamsuwan, et al.
Published: (2009-01-01)

Gleason Score Correlation Between Prostate Needle Biopsy and Radical Prostatectomy Materials
by: Neşe YELDIR, et al.
Published: (2019-09-01)

Neuroendocrine Breast Cancer. Clinical Observation. Personalized Approach
by: Sh. Kh. Gantsev, et al.
Published: (2021-05-01)

Immunohistochemistry for Prostate Biopsy—Impact on Histological Prostate Cancer Diagnoses and Clinical Decision Making
by: Philipp Mandel, et al.
Published: (2021-06-01)

Mouse mammary tumour virus (MMTV) and human breast cancer with neuroendocrine differentiation
by: Lawson JS, et al.
Published: (2017-05-01)

Comparison of Pathology and Prevalence of Prostate Cancer in Patients with PSA between 4-10 ng/ml
by: A Tabibi, et al.
Published: (2008-01-01)

Impact of tertiary Gleason pattern 5 on prostate cancer aggressiveness: Lessons from a contemporary single institution radical prostatectomy series
by: Zachary B. Koloff, et al.
Published: (2015-01-01)

Neuroendocrine Differentiation in Metastatic Conventional Prostate Cancer Is Significantly Increased in Lymph Node Metastases Compared to the Primary Tumors
by: Vera Genitsch, et al.
Published: (2017-07-01)

Factors effective on survival after radical prostatectomy: To what extent is pre-operative biopsy Gleason scoring is confident in predicting the prognosis?
by: Onur Açikgöz, et al.
Published: (2015-01-01)

Importance of prostate-specific antigen (PSA) as a predictive factor for concordance between the Gleason scores of prostate biopsies and RADICAL prostatectomy specimens
by: Nelson Gianni de Lima, et al.
Published: (2013-06-01)

Prognostic significance of Gleason score 7 (3+4) and Gleason score 7 (4+3) in prostatic adenocarcinoma in relation to clinical stage, androgen tissue status and degree of neuroendocrine differentiation
by: Mijović M., et al.
Published: (2014-01-01)

Undergrading and understaging in patients with clinically insignificant prostate cancer who underwent radical prostatectomy
by: Irai S. Oliveira, et al.
Published: (2010-06-01)

Origin of Androgen-Insensitive Poorly Differentiated Tumors in the Transgenic Adenocarcinoma of Mouse Prostate Model
by: Wendy J. Huss, et al.
Published: (2007-11-01)

Pathological upgrading in prostate cancer treated with surgery in the United Kingdom: trends and risk factors from the British Association of Urological Surgeons Radical Prostatectomy Registry
by: Nicholas Bullock, et al.
Published: (2019-10-01)

An Extremely Rare Case of Small Cell Carcinoma in Submandibular Salivary Gland
by: Nigi Ross Philip, et al.
Published: (2017-05-01)

Significance of tertiary Gleason pattern 5 in patients with Gleason score 7 after radical prostatectomy: a retrospective cohort study
by: Li J, et al.
Published: (2019-09-01)

Upgrading of gleason score on radical prostatectomy specimen compared to the pre-operative needle core biopsy: An Indian experience
by: Rishi Nayyar, et al.
Published: (2010-01-01)

A second opinion pathology review improves the diagnostic concordance between prostate cancer biopsy and radical prostatectomy specimens
by: Takanori Maehara, et al.
Published: (2021-01-01)

Prostate carcinoma with neuroendocrine differentiation successfully treated by early detection with imaging examination
by: Momoko Kobayashi, et al.
Published: (2020-11-01)

Histopathological Outcomes after Radical Prostatectomy for Prostate Cancer Based On a New Grading System
by: Sven Nikles, et al.
Published: (2018-01-01)

Survival Significance of Patients With Low Prostate-Specific Antigen and High-Grade Prostate Cancer After Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy
by: Yadong Guo, et al.
Published: (2019-07-01)

Retracted: Histopathological Correlation Between Prostatic Adenocarcinoma in Transrectal Ultrasound Guided Biopsies and Radical Prostatectomy Specimens
by: Mohammad Faisal, et al.
Published: (2020-01-01)

Neuroendocrine differentiation in prostate cancer – a review
by: R. Popescu, et al.
Published: (2015-12-01)

Correlation of Preoperative and Radical Prostatectomy Gleason Score: Examining the Predictors of Upgrade and Downgrade Results
by: Gholamreza Pourmand, et al.
Published: (2017-05-01)

Metastatic malignant melanoma with neuroendocrine differentiation: a case report and review of the literature
by: Carl Christofer Juhlin, et al.
Published: (2020-03-01)

Combined Systematic and MRI-US Fusion Prostate Biopsy Has the Highest Grading Accuracy When Compared to Final Pathology
by: Iulia Andras, et al.
Published: (2021-05-01)

Clinicopathological heterogeneity between primary and metastatic sites of gastroenteropancreatic neuroendocrine neoplasm
by: Huiying Shi, et al.
Published: (2020-09-01)

MRI-Fusion Targeted vs. Systematic Prostate Biopsy–How Does the Biopsy Technique Affect Gleason Grade Concordance and Upgrading After Radical Prostatectomy?
by: Jessica Rührup, et al.
Published: (2019-09-01)

The accuracy of prostate biopsy to assign patients with low-grade prostate cancer to active surveillance
by: Ghleilib, Intisar Ali
Published: (2016)